CIDRAP-RDSP Newsletter: Drug Market Recovery

Resilient Drug Supply Project Newsletter Nov 6, 2020 The Washington Post, CNN, and more Since CIDRAP's sixth COVID-19 report, "Ensuring a Resilient Drug Supply," was published, it has been mentioned by local and national news sources covering the pandemic and its effects. Check out some of the coverage at our RDSP in the News page. Flu vaccine demand creates minor regional US shortages While an early demand for flu vaccines has caused spot shortages, Americans are expected to receive 10.9% to 13.1% more vaccines than last flu season. Read more Experts say COVID-19-affected drug market rebounding Findings offered by the Healthcare Distribution Alliance depict a resilient industry with more potential during COVID-19. Read more News, Publications, and Policies As the first FDA-approved COVID-19 treatment, Veklury (remdesivir, made by Gilead) has also garnered a priority review voucher. | FiercePharma, Nov 3, 2020 The FDA delays some verification requirements of the Drug Supply Chain Security Act while others start Nov 27, 2020. | American Pharmacists Association, Nov 3, 2020 COVID-19 antigen tests are being distributed throughout the country, but their targets vary depending on the state. | The PEW Charitable Trusts, Nov 2, 2020 In a qualitative study, 29 anesthesiologists reflect on how they've navigated drug shortages. | AJOB Empirical Bioethics, Oct 30, 2020 The FDA releases its list of essential medicines, medical countermeasures, and critical inputs as part of Executive Order 13944. | FDA, Oct 30, 2020 Take a closer look at how the FDA's emergency-use authorizations could guide potential COVID-19 vaccines. | Pink Sheet, Oct 28, 2020 DoseID, the first industry consortium focused on RFID use in healthcare, announced its board of directors. | DoseID, Oct 27, 2020 Construction begins on the Medicines Manufacturing Innovation Center, a Scotland facility made to apply innovative manufacturing  to factory-level scales. | Contract Pharma, Oct 26, 2020 For the latest RDSP news, follow @CIDRAP_RDSP on Twitter. Recent Drug Shortages 29 (72.5%) of the 40 COVID-19 drugs are in shortage according to ASHP. 18 (45%) of the 40 COVID-19 drugs are in shortage according to the FDA. 66 (42.3%, ASHP) and 40 (25.6%, FDA) of the 156 critical acute drugs are in shortage. Updated Nov 1, 2020 Food for Thought "The reason we didn't have [more of] a problem with drug shortages during the spring and summer of 2020 was more because we only had a few states—5 to 8—with COVID-19 spikes at a given point in time. It wasn't because the wholesalers and the manufacturers had planned for the pandemic and had the sufficient drugs on hand."  —Stephen Schondelmeyer, RDSP co-principal investigator Contact Us Center for Infectious Disease Research and Policy Academic Health Center, University of Minnesota, Minneapolis, MN Copyright © 2020 Regents of the University of MN Academic Health Center, University of MN Want to change how you receive these emails? You can update your preferences or unsubscribe from this list.